HHS Offers $60M Grants for Strategic Health IT Projects
HHS is providing $60 million in grants for researchers to develop so-called Strategic Health IT Advanced Research Projects to target "breakthrough advances" that overcome barriers to the adoption and meaningful use of health IT.
"Innovative research and approaches are required to overcome some of the foremost challenges we face in achieving our vision of a transformed healthcare system enabled through health IT," said David Blumenthal, MD, HHS' National Coordinator for Health Information Technology.
"The SHARP program will bring together some of the best and brightest minds in the nation to find breakthrough solutions and innovations that will eliminate barriers to adoption and, over time, increase the meaningful use of health IT to improve the health and care of all Americans," Blumenthal said.
Funding for the four-year research period will target:
- Security of health IT research to develop security and risk mitigation policies and the technologies to build and preserve the public trust as health IT systems become ubiquitous.
- Patient-centered cognitive support research to align health IT with the day-to-day practice of clinicians as they provide care.
- Healthcare application and network platform architectures research to achieve electronic exchange and use of health IT securely, privately, and accurately.
- Secondary use of electronic health record data research to improve the overall quality of healthcare, population health, and clinical research, while protecting patient privacy.
- MU Compliance Announcement Sparks Concern, Confusion
- New G-Codes to Pay Doctors for Broad Array of Non-Face-to-Face Care
- Telehealth Improves Patient Care in ICUs
- CMS Sets 2014 Pay Rates for Hospital Outpatient and Physician Services
- Scary Financial Challenges for 2014
- States Rejecting Medicaid Expansion Forgo Billions in Federal Funds
- LifePoint Bolsters Presence in Michigan's Upper Peninsula
- Douglas Hawthorne—A Chance to Do Something Big
- Hospital M&A Volume Up, Value Down in 3Q
- Small Doesn't Mean Doomed